Intuitive Surgical (ISRG) valuation
Intuitive Surgical P/E ratio history
Intuitive Surgical trades at 52.4 times its earnings over the last twelve months and 35.6 times the earnings analysts expect over the next twelve. At its last 9 fiscal year ends its P/E ranged from 33.9 (year to Dec 2016) to 81.3 (year to Dec 2024), with a median of 67.1.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Dec 31, 2025 | $566.36 | $7.87 | 72.0 | 60.1 |
| Dec 31, 2024 | $521.96 | $6.42 | 81.3 | 68.8 |
| Dec 31, 2023 | $337.36 | $5.03 | 67.1 | 54.2 |
| Dec 31, 2022 | $265.35 | $3.65 | 72.7 | 50.2 |
| Dec 31, 2021 | $359.30 | $4.66 | 77.1 | 66.3 |
| Dec 31, 2020 | $272.70 | — | n/m | — |
| Dec 31, 2019 | $197.05 | $3.85 | 51.2 | — |
| Dec 31, 2018 | $159.64 | $3.16 | 50.5 | — |
| Dec 31, 2017 | $121.65 | $1.93 | 63.0 | — |
| Dec 31, 2016 | $70.46 | $2.08 | 33.9 | — |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Intuitive Surgical valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| Intuitive SurgicalISRG | $153B | 52.4 | 35.6 | 13.2 |
| Abbott LaboratoriesABT | $185B | 34.3 | 18.5 | 4.0 |
| MedtronicMDT | $124B | 23.8 | 15.9 | 3.3 |
| StrykerSYK | $112B | 30.2 | 18.6 | 4.3 |
| Boston ScientificBSX | $62.4B | 17.0 | 13.2 | 3.0 |
| Becton DickinsonBDX | $54.5B | 74.5 | 15.1 | 2.6 |
| Edwards LifesciencesEW | $53.0B | 52.9 | 28.9 | 8.1 |
| Idexx LaboratoriesIDXX | $43.5B | 38.7 | 34.9 | 9.6 |
| GE HealthCareGEHC | $34.6B | 16.2 | 14.3 | 1.6 |
| Peer median | 32.3 | 17.2 | 3.6 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: ISRG financials · ISRG returns
No forecast, no recommendation. This page describes Intuitive Surgical from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.